SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure (NVCR) is trending due to the FDA approval of Optune Pax, the first new pancreatic cancer therapy in almost three decades, sparking significant community optimism for a major upward movement. However, some investors express skepticism regarding the therapy's perceived modest survival benefit and the potential for a sell-off by short sellers.

Game asset trading is massive but broken. It is dominated by fragmented platforms, high fees, and unsafe peer to peer deals.  Players who create value should own it. Ownership must be verifiable, transferable, and secure.  OVERTAKE introduces a smart contract based marketplace built for trustless trading, real ownership, and scalable player economies.

OVERTAKE

$TAKE is making serious waves in the Web3 gaming space, trending as trading goes live and a fresh collaboration with Coinflow Labs enables seamless fiat-to-Web3 payments. The community is actively discussing its potential as a GameFi gem, powered by AI market tools and building critical infrastructure for digital assets.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly (FSLY) is trending following a blowout Q4 and FY2025 earnings report, marking an inflection point with record revenue, gross margin, profitability, and strong 2026 guidance, driven partly by AI tailwinds. The community is actively discussing a potential short squeeze and a long-awaited sustained turnaround for the company.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis (AVNT CRYPTO) is trending following its listing on Robinhood and the launch of its AI trading bot, fueling intense community debate around its potential as Coinbase's top perp dex on the Base chain. Bulls are highlighting its low market cap and strong use case compared to rivals like ASTER and HYPE, while others voice frustration over past price action and concerns about transparency.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending with high anticipation surrounding its upcoming earnings report, as the community debates whether strong AI infrastructure demand and the recent strategic acquisition of agentic AI search firm Tavily will lead to a rally or a sell-off, amidst broader market volatility.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is a top trend after announcing its oral obesity drug will advance directly to Phase 3 trials following positive FDA feedback, igniting community debate over a potential short squeeze and significant buyout prospects amidst a rapidly expanding GLP-1 market.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as the community actively discusses its strategic expansion into India for next-generation defense and energy projects, alongside recent widebody engine orders from major airlines. Significant partnerships advancing its Small Modular Reactor and H2-ready power solutions further underscore broad-based growth across its key sectors.

SSgA Active Trust - State Street Consumer Discretionary Select Sector SPDR ETF

Consumer Discretionary Select Sector SPDR Fund

The Consumer Discretionary Select Sector SPDR Fund (XLY) is trending as investors grapple with a bifurcated consumer outlook, influenced by mixed retail spending data and evolving interest rate expectations. While some observe resilient spending, especially among higher-income households, broader community discussion emphasizes concerns about persistent inflation and the ongoing impact of tariffs, with the ETF's performance heavily reliant on major components like Tesla and Amazon navigating their own unique challenges.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is drawing intense community discussion after strong guidance from partner Kioxia fueled further optimism regarding the severe memory shortage and AI-driven demand, while a significant contingent of traders anticipates a sharp correction following its parabolic rise.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending due to a contentious short report from Culper Research alleging stalled test flights and delayed FAA certification, sparking a strong debate among investors. The community is actively countering these claims, emphasizing significant institutional investments from firms like BlackRock and strategic partnerships as key indicators of the company's long-term potential in the burgeoning eVTOL market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.

Virpax Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

Current Price	$0.0107
Prev Close	$0.0111
Open	$0.0107
Dividend Yield	0.00%
50-Day Moving Average	$0.0158
Beta	-2,309.12
Avg. Volume	451.25
PE Ratio	0.00

52-Week High	$11.75
52-Week Low	$0.00
Market Capitalization	$13,295.00
EPS (Annual)	-$70.91
Price to Book	-0.01
Revenue Per Employee	$0.00

VRPX
Virpax Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Latest VRPX News

VRPXVirpax Pharmaceuticals Inc